0
Obstructive Lung Diseases: Airways 4 |

Effectiveness of Omalizumab Treatment in Asthma-COPD Overlap Syndrome

Sibel Atis Nayci, MD; Eylem Ozgur, MD; Esin Tastekin, MD; Cengiz Ozge, MD
Author and Funding Information

Mersin University, Mersin, Turkey


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):867A. doi:10.1016/j.chest.2016.08.967
Text Size: A A A
Published online

Extract

SESSION TITLE: Airways 4

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM

PURPOSE: Omalizumab is indicated for treatment of patients with severe allergic asthma and well defined omalizumab efficacy in this patients, but there are no study regarding effectiveness of omalizumab in patients with Asthma-COPD Overlap Syndrome (ACOS) . ACOS is a syndrome characterized by reversible but persistant airflow limitation which has some features of both asthma and COPD. Frequent and severe exacerbations and related hospitalization are common in ACOS. We aimed to describe our experience with the clinical and functional effectiveness of the omalizumab treatment in patients with ACOS.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543